AcquisitionsJul 9, 2026, 08:09 AM
Stereotaxis Completes Robocath Acquisition
AI Summary
Stereotaxis, Inc. announced the completion of its acquisition of Robocath, an innovator in robotic technologies for interventional cardiology and neurointerventions. Robocath will be fully integrated into Stereotaxis, combining complementary technologies and expertise. This strategic move is expected to accelerate the development of next-generation robotic solutions for various endovascular procedures, strengthening Stereotaxis's leadership in the field and expanding its market reach.
Key Highlights
- Stereotaxis completed its previously announced acquisition of Robocath.
- Robocath will be fully integrated into Stereotaxis.
- The acquisition aims to accelerate development of next-generation robotic solutions.
- Combined expertise will focus on electrophysiology, interventional cardiology, and neurointerventions.
- The deal strengthens Stereotaxis's position as a leader in endovascular robotic technologies.
- Robocath's R-One robotic solution is currently used in Europe and China.
Price Impact
More from STXS